About the webinar:
Healthcare has been an industry under pressure - advances in new technologies, new competitors with different business models, clinical resource constraints and changing - one might say demanding consumer and purchaser expectations have been large and noisy forces pushing change.There have been times in the history of US healthcare where we have had events accelerating those pressures – from the Affordable Care Act to COVID to now.
We are seeing two really new developments: new drugs from GLP-1 and Generative AI converge resulting in our industry re-examining our business models and fundamental aspects of care. Both of these developments have the potential to transform the industry, but we need to understand how best to use the technology and new drugs to responsibly apply to improve care and impact costs.
Speakers:
Julia Hu
CEO & Co-Founder, Lark Health
Julia Hu is an American entrepreneur and the co-founder and CEO of Lark. Founded on the personal experience of having grown up with an undiagnosed chronic condition, Julia is passionate about bringing compassionate care to those struggling with or at risk of chronic disease. Hu was named one of the “Top 10 Women in Tech” by Forbes and was a winner of Inc. Magazine’s “30 under 30”. Prior to founding Lark in 2011, Julia ran global startup incubator, the Clean Tech Open, built a sustainable construction startup, and was an Entrepreneur-in-Residence at Stanford’s StartX incubator. She is on the board of the Council for Diabetes Prevention and a Singularity University faculty member. Hu received her Master’s and Bachelor’s degrees at Stanford University and half of an MBA from MIT Sloan before founding Lark. Julia loves to stay fit with hip hop.
Peter Antall, MD
Chief Medical Officer, Lark Health, President, Medical Network
Peter is a national leader in electronic care delivery, with unique expertise in managing clinical and operations for a leading national telehealth service. He maintains a fervent dedication to providing new health services and programs to meet growing market needs. He demonstrates superior abilities in developing innovative electronic care models, building, recruiting and training a national network, workflow development, quality oversight and management, and resource allocation.
Peter has proven success in executing organizational leadership, including driving commercial success, developing and executing on strategy and assuring organization competitiveness. He is skilled in creating and implementing long-term strategies aimed at constant forward progression and commercial viability. This includes an active role in the core executive team, close collaboration with product and technical teams, subject matter expertise, evangelization and public speaking, regulatory and legislative advocacy. He was also actively involved in the process of achieving IPO.